These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8861801)

  • 1. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
    Agatsuma S; Sekino H; Watanabe H
    Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.
    Niwa T; Miyazaki T; Tsukushi S; Maeda K; Tsubakihara Y; Owada A; Shiigai T
    Nephron; 1996; 74(1):72-8. PubMed ID: 8883023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoxyl-beta-D-glucuronide, the primary emitter of low-level chemiluminescence in plasma of hemodialysis patients.
    Agatsuma S; Sekino H; Nagoshi T; Watanabe H
    Clin Chem; 1994 Aug; 40(8):1580-6. PubMed ID: 8045001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis.
    Takayama F; Taki K; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S142-5. PubMed ID: 12612972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography.
    Niwa T; Takeda N; Tatematsu A; Maeda K
    Clin Chem; 1988 Nov; 34(11):2264-7. PubMed ID: 3141084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
    Atoh K; Itoh H; Haneda M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):220-6. PubMed ID: 19027976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis].
    Król Z; Morawska Z
    Pediatr Pol; 1996 Feb; 71(2):121-5. PubMed ID: 8966077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum indoxyl sulfate is a useful predictor for progression of chronic kidney disease].
    Namba S; Okuda Y; Morimoto A; Kojima T; Morita T
    Rinsho Byori; 2010 May; 58(5):448-53. PubMed ID: 20560454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen (author's transl)].
    Prejac M; Mikulicic V; Jeren-Struić B; Kozjak D
    Lijec Vjesn; 1980; 102(7-8):386-91. PubMed ID: 6169969
    [No Abstract]   [Full Text] [Related]  

  • 11. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
    Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
    Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoxyl sulfate induces nephrovascular senescence.
    Niwa T; Shimizu H
    J Ren Nutr; 2012 Jan; 22(1):102-6. PubMed ID: 22200425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoxyl sulfate, a uremic toxin, is biotransformed from indoxyl-beta-D-glucoside (indican) in rats.
    Hou YC; Tsai SY; Chan SL; Yang SY; Chao PD
    Toxicon; 2008 Sep; 52(3):440-4. PubMed ID: 18619995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    Taki K; Tsuruta Y; Niwa T
    Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients.
    Lin TY; Chou HH; Huang HL; Hung SC
    Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33147880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
    Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure.
    Miyazaki T; Ise M; Hirata M; Endo K; Ito Y; Seo H; Niwa T
    Kidney Int Suppl; 1997 Dec; 63():S211-4. PubMed ID: 9407462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats.
    Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M
    Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.